![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-05/DELV-21391_IND_EuroPCR24_Thorax_Preview_Podcast_1080x1080_0.jpg?VersionId=mCoo6PBI02JqgihgGBjCdkVaTrcxlWcR)
View from the Thoraxcenter: EuroPCR 24 Preview
What's hot at EuroPCR 2024? Watch the View from the Thoraxcenter preview video or listen to the episode on the go!
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.
What is the potential impact of the new data on practice? What details should we look out for? What is the context of the EuroPCR trials?
Read MoreRead Less
![European Examination in Core Cardiology: APSC Exit Examination](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-03/DELV-13669_IND_JAPSC_EP_1_1920x1080.png?VersionId=_8w3YjYZxRnnVGkNVlR32WkHx4ef7Ijw&itok=YV5dcNYp)
In this episode of the Radcliffe Cardiology Podcast, we are joined by Dr Jack Tan (National Heart Centre, SG) and Dr Chris Plummer (The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK), who provide an overview of a recent JAPSC Journal article based on the European Examination in Core Cardiology.
Read More
![View from the Thoraxcenter: What's Hot at ACC.23?](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/MicrosoftTeams-image%20%285%29%20%281%29.png?VersionId=EkO4xhYtwePQNEaHyDbtfM0MSuOxjgkh&itok=-x-DpRKp)
In this episode of "View from the Thoraxcenter," Prof Nicolas Van Mieghem and Dr Joost Daemen preview the most anticipated late-breaking and featured science trials of ACC.23 and discuss their potential impact on patient care and research.
Read More
![Ep 1: Breaking the Cycle of HFpEF and Atrial Fibrillation](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-12902_IND_CFR_EP_1_1920x1080.png?VersionId=TzS65EpdM.JsJxP.B1eP_v9y5IAzpG.o&itok=hPMTCbVj)
In this episode, key discussion topics include: - Diagnosis, treatment and patient wellbeing for comorbid HFpEF and AF - Adverse event rates and prognostic implications for HFpEF and AF, and how we can close the gaps in the diagnostic challenges - Approaches and critical steps to patient management.
Read More
![Ep 11: Sex Differences in Hypertension: Diagnosis, Awareness, and Control](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-11091_ECR_EP_11_1920x1080%20v3.png?VersionId=HEPtOUkoJnFkOQ8cH3Qp.vkhUwZvtp1r&itok=OBLNLrMc)
In the third part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Renata Cifkova (Institute of Experimental Medicine, Prague, CZ) to discuss the diagnosis of hypertension in women, including how we can raise awareness for this issue.
Read More
![Ep 10: Sex Differences in Hypertension: Cardiovascular complications](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9617_ECR_EP_10_1920x1080%20v3.png?VersionId=311gS_Qql6xzcHJdonGWujbd7FLMgB_H&itok=KlyNfAc_)
In the second part of ECR Podcast's series on sex-differences in hypertension, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Dr Angela Maas (Radboud University Medical Center, Nijmegen, NL) to talk about the cardiovascular complications that may arise in women as a result of hypertension.
Read More
![Ep 9: Sex Differences in Hypertension: Pharmacological Treatment](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9601_ECR_EP_9_1920x1080%20v3.png?VersionId=nCxO.HFAMlDaoa97AIyluRc.84J.YW8d&itok=vDNVphfl)
In the first of a three-part ECR Podcast series on hypertension in women, Dr Isabella Sudano (University Hospital and University of Zurich, Zurich, CH) and Dr Eva Gerdts (Haukeland University Hospital, Bergen, NO) are joined by Prof Juan Tamargo (University Complutense, Madrid, ES) to discuss pharmalogical treatment options and considerations.
Read More
![Ep 8: The Role of CT Coronary Angiography in Chronic Total Occlusion Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9963_ECR_EP_8_1920x1080%20v3.png?VersionId=H_PpHdkBlsXWwIM3CU7OKBWfwKsIMhOC&itok=O0IMbo0q)
What considerations must be made when screening chronic total occlusion patients undergoing PCI, and how can CT be used in daily practice?
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
Read More
In this month's episode of ECR Podcast, Dr Vinoda Sharma, (Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK) and Dr Abdul Mozid, (Leeds Teaching Hospitals NHS Trust, Leeds, UK) discuss the ways in which CT coronary angiography can be utilised in chronic total occlusion percutaneous coronary interventions, and how the procedures differ across their UK-based practices.
![Ep 7: Socioeconomic Factors Impacting Coronary and Structural Intervention](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9732_ECR_EP_7_1920x1080%20v3.png?VersionId=fgC9qTTpBbEunJ3lA84.aIkG9IzVbjOr&itok=CFcrw78V)
What are the social factors that impact access to coronary and structural intervention in the current landscape of cardiology? In this month's episode of ECR Podcast, guest editor of ECR's special focus on gender disparities in interventional and structural heart procedures, Dr Natalia Berry (Mid Atlantic Permanente Medical Group, Washington DC, USA) is joined by Dr Renee Bullock-Palmer, (Deborah Heart and Lung Center, Pemberton, NJ, USA) to answer some of these questions.
Read More
![Ep 6: Inflammatory Biomarkers and Cardiovascular Risk](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-02/DELV-9377_ECR_EP_6_1920x1080%20v3.png?VersionId=2TBpob7jjjEZqtHM9MlG6vf3aq2uUdnt&itok=zCk6OoPd)
What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event?
Read More
![Targeting Inflammation in Atherosclerosis: Current Guidelines and Clinical Data](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-6314_NN_Kaski_Fiolet_1920x1080.png?VersionId=zzBXlqg17rbiXsBjYW5OHA7u7mXUg3qd&itok=8f3Ze18J)
Join Prof Juan Carlos Kaski (St George’s University of London, UK) and Dr Aernoud Fiolet (University Medical Center Utrecht, Netherlands) as they explore topics such as how guidelines currently view anti-inflammatory approaches and main molecules under investigation.
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
Read More
Supported by an unrestricted educational grant from NOVO NORDISK A/S.
![View from the Thoraxcenter: EuroPCR 24 Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-21391_IND_EuroPCR24_Thorax_Preview_1920x1080%20%284%29.jpg?VersionId=8qyeeDxvcVDdQZsPgTEhAwVCTc0aODqO&itok=7o8k40g6)
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC's Thoraxcenter for an insightful preview of the late-breaking science data to look out for at the 2024 EuroPCR meeting.
Read More
![View from the Thoraxcenter: ACC.24 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20924_IND_ACC24_Thorax_WrapUp_1920x1080.jpg?VersionId=xzLdpFYniyRYKPTn_ur0Y2fQaS7_opns&itok=sGRB01cj)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.
Read More
![ACC.24 Late-breaking Science Preview](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-20712_IND_ACC24_Thorax_Preview_1920x1080.jpg?VersionId=NZKBAeYuVFEq8_A4QuFzbZA.NKmJIsRC&itok=VvuyX-1B)
What’s hot at ACC.24?
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
Read More
Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.
![VHPSD versus Conventional Catheter Ablation in AF](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-12/DELV-17876_RC-Podcast_Pranata_1920x1080.jpg?VersionId=0ilpkImVw.IBhFa4HGsGbSL4yh_oxl_L&itok=IiYOCsWw)
In this episode of the Radcliffe Podcast, we are joined by Dr Raymond Pranata, Dr Mohammad Iqbal and Dr Giky Karwiky (Hasan Sadikin General Hospital, Bandung, Indonesia) as they discuss their recently published systematic review and meta-analysis of very-high-power short-duration ablation as compared to conventional ablation for the treatment of pulmonary vein isolation in atrial fibrillation.
Read More
![View from the Thoraxcenter: AHA 23 Wrap Up](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-01/DELV-18484_AHA23_Thorax_WrapUp_1920x1080.jpg?VersionId=CTt7WafRTqAlQLoC2ccc408sW3gfqwrX&itok=Fi6ZvQl5)
Join Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) as they review the latest late-breaking science data from AHA Scientific Sessions 2023.
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.
Read More
They interpret the evidence from five key trials, providing context, asking thought-provoking questions to translate the data into key take-home messages for practice and research.